NCT04548349View on ClinicalTrials.gov

Profiling the Skin Microbiome in Response to Altreno in Acne Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

April 23, 2021

Primary Completion Date

August 22, 2022

Study Completion Date

August 22, 2022

Conditions

AcneHealthy

Interventions

DRUG

Altreno

Acne patients will be assigned to Altreno once daily.

DRUG

Benzoyl peroxide

Acne patients will be assigned to BPO leave-on gel once daily.

Trial Locations (1)

02115

Beth Israel Deacones Medical Center, Boston

Sponsors

Collaborators (1)

Ortho Dermatologics

All Listed Sponsors

collaborator

Ortho Dermatologics

INDUSTRY

lead

Beth Israel Deaconess Medical Center

OTHER